Back to top
more

Cumberland Pharmaceuticals (CPIX)

(Delayed Data from NSDQ)

$1.41 USD

1.41
12,556

0.00 (0.00%)

Updated Aug 5, 2024 03:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 39% (154 out of 251)

Industry: Medical - Drugs

Better trading starts here.

Zacks News

New Strong Sell Stocks for December 4th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today

Cumberland Pharmaceuticals (CPIX) Dips More Than Broader Markets: What You Should Know

Cumberland Pharmaceuticals (CPIX) closed at $5.56 in the latest trading session, marking a -0.18% move from the prior day.

What's in Store for Cumberland Pharma (CPIX) in Q3 Earnings?

Cumberland Pharmaceuticals' (CPIX) third-quarter results are expected to reflect solid sales growth.

Cumberland Pharmaceuticals (CPIX) to Report Q3 Results: Wall Street Expects Earnings Growth

Cumberland (CPIX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Cumberland Pharmaceuticals (CPIX) Outpaces Stock Market Gains: What You Should Know

Cumberland Pharmaceuticals (CPIX) closed at $5.34 in the latest trading session, marking a +0.75% move from the prior day.

Cumberland Pharmaceuticals (CPIX) Stock Sinks As Market Gains: What You Should Know

Cumberland Pharmaceuticals (CPIX) closed at $5.30 in the latest trading session, marking a -1.6% move from the prior day.

Cumberland Pharmaceuticals (CPIX) Dips More Than Broader Markets: What You Should Know

Cumberland Pharmaceuticals (CPIX) closed at $5.44 in the latest trading session, marking a -1.72% move from the prior day.

Cumberland Pharmaceuticals (CPIX) Outpaces Stock Market Gains: What You Should Know

In the latest trading session, Cumberland Pharmaceuticals (CPIX) closed at $5.67, marking a +1.61% move from the previous day.

Cumberland Pharmaceuticals (CPIX) Stock Sinks As Market Gains: What You Should Know

Cumberland Pharmaceuticals (CPIX) closed the most recent trading day at $5.70, moving -1.38% from the previous trading session.

Tirthankar Chakraborty headshot

New Strong Buy Stocks for September 26th

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Thursday

Tirthankar Chakraborty headshot

New Strong Buy Stocks for September 19th

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Thursday

Cumberland Pharmaceuticals Sees Hammer Chart Pattern: Time to Buy?

Cumberland Pharmaceuticals has been struggling lately, but the selling pressure may be coming to an end soon.

Cumberland (CPIX) Upgraded to Strong Buy: What Does It Mean for the Stock?

Cumberland (CPIX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Tirthankar Chakraborty headshot

New Strong Buy Stocks for September 12th

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Thursday

Theravance Announces Positive Early Data on JAK Inhibitor

Theravance's (TBPH) investigational JAK inhibitor TD-8236 demonstrates favorable results from a phase I study for treating inflammatory lung diseases.

Tirthankar Chakraborty headshot

New Strong Buy Stocks for September 9th

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Monday

Here is Why Growth Investors Should Buy Cumberland (CPIX) Now

Cumberland (CPIX) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Tirthankar Chakraborty headshot

New Strong Buy Stocks for September 5th

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Thursday

Here is Why Growth Investors Should Buy Cumberland (CPIX) Now

Cumberland (CPIX) could produce exceptional returns because of its solid growth attributes.

Cumberland Pharmaceuticals (CPIX) Q2 Earnings Beat Estimates

Cumberland (CPIX) delivered earnings and revenue surprises of 42.86% and -8.01%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

Cumberland Pharmaceuticals (CPIX) Earnings Expected to Grow: What to Know Ahead of Q2 Release

Cumberland (CPIX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Dova Pharmaceuticals (DOVA) in Focus: Stock Moves 9.1% Higher

Dova Pharmaceuticals (DOVA) shares rose more than 9% in the last trading session, amid huge volumes.

Acer Shares Down on FDA's CRL for Genetic Disorder Treatment

Acer Therapeutics Inc. (ACER) receives a Complete Response Letter from the FDA regarding its new drug application for Edsivo for the treatment of vascular Ehlers-Danlos syndrome.

Cumberland Pharmaceuticals (CPIX) Gains As Market Dips: What You Should Know

In the latest trading session, Cumberland Pharmaceuticals (CPIX) closed at $6.35, marking a +0.79% move from the previous day.

Why Taro Pharmaceutical (TARO) Could Be Positioned for a Slump

Taro Pharmaceutical (TARO) has witnessed a significant price decline in the past four weeks, and is seeing negative earnings estimate revisions as well.